Promentis Pharmaceuticals, Inc.

Venture capital investors put $2.2bn into 128 biopharmaceutical companies in the first quarter of this year and at the rate that VC firms are raising new funds, 2017 could be another big financing yea

Company Changes BANTOCK , Pete To: Accelerate Diagnostics Inc. , Chief Commercial Officer (July) From: Ventana Medical Systems Inc., General Mgr., North American Commercial Ops. Phone: 520-365-31

Start-Up Execs Avaxia Biologics Inc. Neil L. Schauer, PhD To: VP, Technical Ops. (July) From: VP, Process Sciences, Inspiration Biopharmaceuticals Inc. Phone: 781-861-0062 BiologicsMD Inc. J.

Garnet BioTherapeutics Inc. 1 Great Valley Parkway Suite 12 Malvern, PA 19355 Phone: (610) 240-4150 E-Mail: info@garnetbio.com Web Site: www.garnetbio.com Management: Gerri Henwood, CEO; Gene Kopen, P